Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. BioMD Plus LLC
WARNING LETTER
•BioMD Plus LLC•February 28, 2022

FDA WARNING_LETTER - BioMD Plus LLC - February 28, 2022

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On May 4, 2022, the FDA issued a Warning Letter to Jonathan Levitt regarding products sold on www.biomdplus.com and associated social media. The FDA reviewed the website in February 2022 and found that the company sells human and animal products containing CBD or Delta-8 THC.

The FDA determined that the human products, including "CBD Oil," "CBD Capsules," "Vegan CBD Gummies," "CBD Pain Relief Cream," "Delta 8 THC Gummies," and "Delta 8 THC Vape Cartridge," are unapproved new drugs, violating sections 505(a) and 301(d) of the FD&C Act. These products are also misbranded drugs under section 502(f)(1) due to inadequate directions for use. The "Delta 8 THC Gummies" are additionally considered adulterated food under section 402(a)(2)(C)(i) because Delta-8 THC is an unsafe food additive, not generally recognized as safe (GRAS).

The "Natural Pet CBD Oil" is classified as an unapproved new animal drug, unsafe under section 512(a) and adulterated under section 501(a)(5) of the FD&C Act. The FDA cited numerous claims from the company's website and social media, such as treating stress, depression, psychosis, Alzheimer's, Crohn's disease,

Company
BioMD Plus LLC
Inspection Date
February 28, 2022
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald D. Ashley (Director)
  • Neal Bataller (Division Director)
  • Ann M. Oxenham (Director)
Open in Dashboard

ID · 7c73c09e-6f4f-45a8-b1e7-339c0fdae79f

Violation Codes10
21 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)21 U.S.C. 342(a)(2)(C)(i)21 U.S.C. 321(ff)21 U.S.C. 321(ff)(3)(B)(i)21 U.S.C. 321(ff)(3)(B)(ii)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.